DISC1 regulates expression of the neurotrophin VGF through the PI3K/AKT/CREB pathway

Journal of Neurochemistry

Volumn 135, Issue 3, 2015, Pages 598-605

  Rodríguez Seoane, Carmen ^a   Ramos, Adriana ^a,b   Korth, Carsten ^c   Requena, Jesús R ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Orthopedic Surgery   (Germany)

Author keywords

AKT; CREB; DISC1; GSK3 ; PI3K; VGF

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; NEUROTROPHIN; NEUROTROPHIN VGF; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PHOSPHODIESTERASE IV; PROTEIN KINASE B; UNCLASSIFIED DRUG; CREB1 PROTEIN, MOUSE; DISC1 PROTEIN, MOUSE; NERVE GROWTH FACTOR; NERVE PROTEIN; NEUROPEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; VGF PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; FEMALE; MENTAL DISEASE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENE SILENCING; METABOLISM; PHYSIOLOGY; PREGNANCY;

ANIMALS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; MICE; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEUROPEPTIDES; PHOSPHATIDYLINOSITOL 3-KINASES; PREGNANCY; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84945463586     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13258     Document Type: Article

References (39)

1. Alder J., Thakker-varia S., Bangasser D. A., Kuroiwa M., Plummer M. R., Shors T. J., and, Black I. B., (2003) Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity. J. Neurosci. 23, 10800-10808.
2. Bonni A., Ginty D. D., Dudek H., and, Greenberg M. E., (1995) Serine 133-phosphorylated CREB induces transcription via a cooperative mechanism that may confer specificity to neurotrophin signals. Molecular and cellular neurosciences. 6, 168-183.
3. Bradshaw N. J., Ogawa F., Antolin-Fontes B., Chubb J. E., Carlyle B. C., Christie S., Claessens A., Porteous D. J., and, Millar J. K., (2008) DISC1, PDE4B, and NDE1 at the centrosome and synapse. Biochem. Biophys. Res. Commun. 377, 1091-1096.
4. Bradshaw N. J., Soares D. C., Carlyle B. C., Ogawa F., Davidson-Smith H., Christie S., Mackie S., Thomson P. A., Porteous D. J., and, Millar J. K., (2011) PKA phosphorylation of NDE1 is DISC1/PDE4 dependent and modulates its interaction with LIS1 and NDEL1. J. Neurosci. 31, 9043-9054.
5. Brandon N. J., and, Sawa A., (2011) Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat. Rev. Neurosci. 12, 707-722.
6. Brandon N. J., Handford E. J., Schurov I., Rain J.-C., Pelling M., Duran-Jimeniz B., Camargo L. M., Oliver K. R., Beher D., Shearman M. S., and, Whiting P. J., (2004) Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders. Mol. Cell Neurosci. 25, 42-55.
7. Busse S., Bernstein H.-G., Busse M., Bielau H., Brisch R., Mawrin C., Müller S., et al,. (2012) Reduced density of hypothalamic VGF-immunoreactive neurons in schizophrenia: a potential link to impaired growth factor signaling and energy homeostasis. Eur. Arch. Psychiatry Clin. Neurosci. 262, 365-374.
8. Cattaneo A., Sesta A., Calabrese F., Nielsen G., Riva M. A., and, Gennarelli M., (2010) The expression of VGF is reduced in leukocytes of depressed patients and it is restored by effective antidepressant treatment. Neuropsychopharmacology 35, 1423-1428.
9. Cross D. A., Alessi D. R., Cohen P., Andjelkovich M., and, Hemmings B. A., (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789.
10. Fiols C. J., Williams J. S., Chouon C., Wang Q. M., Roach P. J., and, Andrisanioll O. M., (1994) A secondary phosphorylation of CREB341 at Serf2 'is required for the CAMP-mediated control of gene expression. 12. The Journal of Biological Chemistry. 269, 32187-32193.
11. Grimes C. A., and, Jope R. S., (2001) CREB DNA binding activity is inhibited by glycogen synthase kinase-3β and facilitated by lithium. J. Neurochem. 78, 1219-1232.
12. Gu H., Maeda H., Moon J. J., Lord J. D., Yoakim M., Nelson B. H., and, Neel B. G., (2000) New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway. Mol. Cell. Biol. 20, 7109-7120.
13. Hawley J., and, Wagner J. A., (1992) NGF induces the expression response element of the VGF gene through a CAMP. J. Neurosci. 12, 2573-2581.
14. Hayashi-Takagi A., Takaki M., Graziane N., Seshadri S., Murdoch H., Dunlop A. J., Makino Y., et al,. (2010) Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat. Neurosci. 13, 327-332.
15. Holgado-Madruga M., Moscatello D. K., Emlet D. R., Dieterich R., and, Wong A. J., (1997) Grb2-associated binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth factor. Proc. Natl Acad. Sci. USA 94, 12419-12424.
16. Hunsberger J. G., Newton S. S., Bennett A. H., Duman C. H., Russell D. S., Salton S. R., and, Duman R. S., (2007) Antidepressant actions of the exercise-regulated gene VGF. Nat. Med. 13, 1476-1482.
17. Hur E.-M., and, Zhou F.-Q., (2010) GSK3 signalling in neural development. Nat. Rev. Neurosci. 11, 539-551.
18. Ishizuka K., Kamiya A., Oh E. C., Kanki H., Seshadri S., Robinson J. F., Murdoch H., et al,. (2011) DISC1-dependent switch from progenitor proliferation to migration in the developing cortex. Nature 473, 92-96.
19. Itoh T., Tokumura M., and, Abe K., (2004) Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats. Eur. J. Pharmacol. 498, 135-142.
20. Kranz K., Warnecke A., Lenarz T., Durisin M., and, Scheper V., (2014) Phosphodiesterase type 4 inhibitor rolipram improves survival of spiral ganglion neurons in vitro. PLoS ONE 9, e92157.
21. MacDonald J. I., Gryz E. A., Kubu C. J., Verdi J. M., and, Meakin S. O., (2000) Direct binding of the signaling adapter protein Grb2 to the activation loop tyrosines on the nerve growth factor receptor tyrosine kinase, TrkA. J. Biol. Chem. 275, 18225-18233.
22. Mai L., Jope R. S., and, Li X., (2002) BDNF-mediated signal transduction is modulated by GSK3 b and mood stabilizing agents. Journal of Neurochemistry 7, 5-83.
23. Mao Y., Ge X., Frank C. L., Madison J. M., Koehler A. N., Doud M. K., Tassa C., et al,. (2009) Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell 136, 1017-1031.
24. Millar J. K., Wilson-annan J. C., Anderson S., Christie S., Martin S., Semple C. A. M., Devon R. S., et al,. (2000) Disruption of two novel genes by a translocation co-segregating with schizophrenia. Human Molecular Genetics 9, 1415-1424.
25. Millar J. K., Pickard B. S., Mackie S., James R., Christie S., Buchanan S. R., Malloy M. P., et al,. (2005) DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 310, 1187-1191.
26. Ming G., and, Song H., (2009) DISC1 partners with GSK3beta in neurogenesis. Cell 136, 990-992.
27. Murdoch H., Mackie S., Collins D. M., Hill E. V., Bolger G. B., Klussmann E., Porteous D. J., Millar J. K., and, Houslay M. D., (2007) Isoform-selective susceptibility of DISC1/phosphodiesterase-4 complexes to dissociation by elevated intracellular cAMP levels. J. Neurosci. 27, 9513-9524.
28. Ramos A., Rodríguez-Seoane C., Rosa I., Trossbach S. V., Ortega-Alonso A., Tomppo L., Ekelund J., et al,. (2014) Neuropeptide precursor VGF is genetically associated with social anhedonia and underrepresented in the brain of major mental illness: its downregulation by DISC1. Hum. Mol. Genet. 23, 5859-5865.
29. Schaal S. M., Garg M. S., Ghosh M., Lovera L., Lopez M., Patel M., Louro J., et al,. (2012) The therapeutic profile of rolipram, PDE target and mechanism of action as a neuroprotectant following spinal cord injury. PLoS ONE 7, e43634.
30. Seshadri S., Kamiya A., Yokota Y., Prikulis I., Kano S., Hayashi-Takagi A., Stanco A., et al,. (2010) Disrupted-in-schizophrenia-1 expression is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade. Proc. Natl Acad. Sci. USA 107, 5622-5627.
31. Shimazawa M., Tanaka H., Ito Y., Morimoto N., Tsuruma K., Kadokura M., Tamura S., et al,. (2010) An inducer of VGF protects cells against ER stress-induced cell death and prolongs survival in the mutant SOD1 animal models of familial ALS. PLoS ONE 5, e15307.
32. Shinoda T., Taya S., Tsuboi D., Hikita T., Matsuzawa R., Kuroda S., Iwamatsu A., and, Kaibuchi K., (2007) DISC1 regulates neurotrophin-induced axon elongation via interaction with Grb2. J. Neurosci. 27, 4-14.
33. St Clair D., Blackwood D., Muir W., Carothers A., Walker M., Spowart G., Gosden C., and, Evans H. J., (1990) Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336, 13-16.
34. Thakker-Varia S., and, Alder J., (2009) Neuropeptides in depression: role of VGF. Behav. Brain Res. 197, 262-278.
35. Thakker-Varia S., Krol J. J., Nettleton J., Bilimoria P. M., Bangasser D. A., Shors T. J., Black I. B., and, Alder J., (2007) The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus. J. Neurosci. 27, 12156-12167.
36. Thakker-Varia S., Jean Y. Y., Parikh P., Sizer C. F., Jernstedt Ayer J., Parikh A., Hyde T. M., Buyske S., and, Alder J., (2010) The neuropeptide VGF is reduced in human bipolar postmortem brain and contributes to some of the behavioral and molecular effects of lithium. J. Neurosci. 30, 9368-9380.
37. Thomson P. A., Malavasi E. L. V., Grünewald E., and, Soares D. C., (2013) DISC1 genetics, biology and psychiatric illness. Front Biol (Beijing), 8, 1-31.
38. Zhang M., Shi J., Huang Y., and, Lai L., (2012) Expression of canonical WNT/β-CATENIN signaling components in the developing human lung. BMC Dev. Biol. 12, 21.
39. Zhu J., Mix E., and, Winblad B., (2001) The antidepressant and antiinflammatory effects of rolipram in the central nervous system. CNS Drug Rev. 7, 387-398.